CHEK1 and hepatocellular carcinoma: As shown in Figure 1E, DHMMF treatment considerably increased the phosphorylation levels of Wee1 (Ser642) and decreased the phosphorylation levels of Chk1 (Ser317) in the human HCC cells, suggesting that DHMMF impairs the G2/M checkpoint functions in human HCC cells.